Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Merck
Argus Health
Farmers Insurance
US Department of Justice
US Army
Mallinckrodt
Julphar
Fish and Richardson
Johnson and Johnson

Generated: January 17, 2018

DrugPatentWatch Database Preview

Hydrocortisone sodium succinate - Generic Drug Details

« Back to Dashboard

What are the generic sources for hydrocortisone sodium succinate and what is the scope of hydrocortisone sodium succinate freedom to operate?

Hydrocortisone sodium succinate
is the generic ingredient in three branded drugs marketed by Abbott, Hospira, Abraxis Pharm, Baxter Hlthcare, Intl Medication, Watson Labs, and Pharmacia And Upjohn, and is included in twenty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty drug master file entries for hydrocortisone sodium succinate. Two suppliers are listed for this compound.
Pharmacology for hydrocortisone sodium succinate

US Patents and Regulatory Information for hydrocortisone sodium succinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm HYDROCORTISONE SODIUM SUCCINATE hydrocortisone sodium succinate INJECTABLE;INJECTION 088669-001 Jun 8, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs HYDROCORTISONE SODIUM SUCCINATE hydrocortisone sodium succinate INJECTABLE;INJECTION 084738-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbott A-HYDROCORT hydrocortisone sodium succinate INJECTABLE;INJECTION 089580-001 Apr 11, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abraxis Pharm HYDROCORTISONE SODIUM SUCCINATE hydrocortisone sodium succinate INJECTABLE;INJECTION 088668-001 Jun 8, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abraxis Pharm HYDROCORTISONE SODIUM SUCCINATE hydrocortisone sodium succinate INJECTABLE;INJECTION 088712-001 Jun 8, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira A-HYDROCORT hydrocortisone sodium succinate INJECTABLE;INJECTION 085930-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira A-HYDROCORT hydrocortisone sodium succinate INJECTABLE;INJECTION 040666-001 Apr 6, 2006 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abraxis Pharm HYDROCORTISONE SODIUM SUCCINATE hydrocortisone sodium succinate INJECTABLE;INJECTION 088670-001 Jun 8, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn SOLU-CORTEF hydrocortisone sodium succinate INJECTABLE;INJECTION 009866-002 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira A-HYDROCORT hydrocortisone sodium succinate INJECTABLE;INJECTION 085931-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Julphar
Teva
Federal Trade Commission
Daiichi Sankyo
US Army
Farmers Insurance
Cipla
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot